We have recently reported that Tregs co-expressing FoxP3 and Helios represent a functional subset with stronger suppressive characteristics [5], and FoxP3/Helios co-expression with GARP/LAP can be used to identify expanded Treg subsets in cancer patients [50]. This evidence concerns the gene FOXP3 and cancer.